SWOT Analysis for Bliss GVS Pharma Ltd.

Positive Breakout Third Resistance ( LTP > R3)
Results declared today, with net profit and revenue growth YoY and QoQ
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
Undervalued Growth Stocks
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Companies with high TTM EPS Growth
Best Bargains Screener: Above line growth, Below line valuations
PEG lower than Industry PEG
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Results in the last two days with YoY and QoQ Net Profit Growth
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
High Volume, High Gain
Top Gainers
High Volume, High Gain
New 52 Week High
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Insiders bought stocks
Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
Decline in Quarterly Net Profit (YoY)
Increasing Trend in Non-Core Income

Mutual Funds Increased Shareholding over the Past Two Months

Promoters increasing shareholding QoQ
Rising Delivery Percentage Compared to Prev Day
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Bliss GVS Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats